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This study describes the synthesis of fourteen thiazinanones from a multicomponent reaction 
of 2-morpholinoehtylamine (as primary amine), arenealdehydes (as carbonyl compound) and the 
mercaptopropionic acid using both conventional (thermal heating) and ultrasound methodologies. 
Through thermal heating methodology, the thiazinanones were obtained in 49 to 97% yields for 
16 hours and through sonochemistry methodology, the reaction time was reduced for 25 minutes 
with yields 41 to 88%. The full identification and characterization of unpublished heterocycles were 
achieved by proton (1H) and carbon 13 (13C) nuclear magnetic resonance (NMR) spectroscopy, 
mass spectrometry and infrared. Some of them were also characterized by elemental analysis. 
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Introduction
The cleaner ultrasound methodology has been very 
effective in organic synthesis, especially in cases where 
the reactions take too much time.1 The effect of cavitation 
promotes the formation, growth and collapse of bubbles 
in the irradiated liquid. Consequently, the resulting high 
temperature and pressure inside the bubbles enhances mass 
transfer and a turbulent flow in the liquid and the reaction 
time is reduced.2,3 
Multicomponent reaction is a modern and environmental 
friendly synthetic strategy, wherein three or more starting 
materials are converted into one product. This kind of 
reaction has attracted interest in organic synthesis due the 
various advantages, such as reduction in reaction times, 
economy of the atoms and simplification of the synthetic 
procedures. This approach has also been widely exploited 
in medicinal chemistry for obtaining bioactive compound 
libraries4 including heterocycles.5
Small heterocyclic moieties containing atoms of nitrogen, 
sulfur and oxygen have been extensively studied due to their 
diverse biological activities. Sonochemistry has been also 
studied to the synthesis of heterocycles, such as thiazoles,6 
thiophenes,7 thiazines8 and thiadiazines.9 Our research 
group and others recently published the efficient ultrasound 
synthesis of thiazolidinones10-13 and thiazolidinediones.14 
Thiazinanones also belongs to this heterocyclic class and it 
is important to note that, to our knowledge, the application 
of sonochemistry to the synthesis of thiazinanones has not 
been reported in the literature.
Six-membered thiazinanones show important biological 
properties as antioxidant, anti-inflammatory, anti-diabetic 
and antimicrobial.15-18 The strategies to the synthesis of 
thiazinanones are quite similar to the strategies to the 
synthesis of analogue five-membered thiazolidinones. 
Thus, thiazinanones could be obtained by a multicomponent 
reaction between a primary amine, an aldehyde (or ketone) 
and the mercaptopropionic acid15,17,19 or by a reaction 
between thioureas and β-propylhaloacetic acid.18 Moreover, 
these methods can be applied in two steps, multicomponent 
(all reactants together in the beginning of reaction) or one-
pot reactions, under catalysis or not. 
These observations associated to the crescent interest 
in multicomponent reactions encouraged us to evaluate 
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the effect of ultrasound on the three component synthesis 
of novel thiazinanones from 2-morpholinoehtylamine, 
arenealdhydes and mercaptopropionic acid. For comparative 
purpose, the reactions were performed in the presence and 
in the absence of ultrasonic irradiation, i.e., by conventional 
method. 
Experimental
Material and methods
Reagents and solvents were purchased from Sigma-
Aldrich (St. Louis, MO, USA) and were used without 
additional purification. Reactions in ultrasound were carried 
out with a microtip probe (3 mm) connected to a 500 W 
Sonics Vibra-Cell ultrasonic processor (Sonics & Materials, 
Inc., Newtown, CT, USA), operating at 20 kHz (25% of 
the maximum power output). Reactions were monitored by 
thin layer chromatography (silica gel 60 F253, ultraviolet 
254 nm) and gas chromatography, in a gas chromatograph 
(GC) GC-2010 (Shimadzu Corp., Kyoto, Japan) with a 
column ID of 0.25 mm and length of 30 m. The analyses 
were carried out with a 14 psi column head pressure. The 
temperature range was 50 °C (2 min) to 250 °C (10 min) 
with a 16 °C min−1 rate. Temperatures of the injector 
and detector were 250 and 270 °C, respectively. Gas 
chromatography with mass spectrometer (GC-MS) analyses 
was performed on a GC-2010 plus GCMS-QP2010 SE 
system AOC-20i auto injector (Shimadzu, Kyoto, Japan). 
Proton (1H) and carbon 13 (13C) nuclear magnetic resonance 
(NMR) spectra were recorded on a Bruker DRX 400 
spectrometer (400.14 MHz for 1H and 100.61 MHz for 13C) 
or on a Bruker AVANCE 600 spectrometer (600.17 MHz 
for 1H and at 150.91 MHz for 13C) or on a Bruker AC 200 F 
spectrometer (1H at 200.13 MHz and 13C at 50.32 MHz; 
Billerica, MA, USA) in CDCl3 containing tetramethylsilane 
(TMS) as internal standard. The 13C NMR spectrum of 
compound 5k was recorded on Bruker AVANCE 500 
spectrometer (125.75 MHz). The fids were processed in 
the MestReC 4.7.0.0 (Mestrelab Research SL, Santiago de 
Compostela, Spain) or in the TopSpin (Bruker, Billerica, 
MA, USA) softwares. Figure 1 shows the atom-numbering 
for thiazinanones 5a-n to the identification of NMR signals. 
Infrared (IR) spectra were obtained in attenuated total 
reflectance (ATR) on a IV Agilent absorption spectrometer, 
model Cary 630 FTIR (Agilent Technologies, Santa 
Clara, CA, USA). The elemental analyses (C, H and 
N) were used for thiazinanones 5a, 5b, 5c and 5g on a 
2400 Series II CHNS/O Analyser equipment (PerkinElmer, 
Waltham, MA, USA). Analyses were consistent within 
ca. 0.4 theorical values.
General procedure for the synthesis of 2-(aryl)-3-(2-
morpholinoethyl)-1,3-thiazinan-4-ones
Synthesis of thiazinanones 5a-n by thermal heating 
methodology
In a 100 mL flask with a Dean-Stark apparatus, toluene 
(50 mL), 2-morpholinoethylamine [4-(2-aminoethyl)
morpholine] 2 (1 mmol) and corresponding arenealdehyde 
1a-n (1 mmol) were added and the reaction mixture 
was heated at 110 ºC for 3 h. After this time, the 
mercaptopropionic acid 4 (2 mmol) was added and the 
mixture was heated for additional 16 h. The reaction 
mixture was washed with saturated solution of NaHCO3 
(3 × 30 mL), dried with MgSO4 and concentrated in vacuo 
to give the expected thiazinanones. When necessary, the 
compounds were washed with a hot hexane to furnish the 
pure compounds.
Synthesis of thiazinanones 5a-n by ultrasound methodology
A mixture of 2-morpholinoethylamine 2 (1 mmol), 
arenealdehyde 1a-n (1 mmol) and mercaptopropionic 
acid 4 (3 mmol) in toluene (10 mL) was sonicated for 
25 min in an ultrasonic probe with frequency of 20 kHz. 
The organic layer was washed with a saturated solution of 
NaHCO3 (3 × 30 mL), dried with MgSO4 and concentrated 
in vacuo to generate the products without purification. 
Selected data for the thiazinanones 5a-n 
3-(2-Morpholinoethyl)-2-(2-nitrophenyl)-1,3-thiazinan-4-
one (5a)
Yellow oil; IR (ATR) νmax / cm−1: 2951 (C-Hsp2 stretch), 
2866-2816 (C-Hsp3 stretch), 1615 (C=O stretch), 1528-1462 
(aromatic C=C stretch), 1525 and 1357 (NO2 stretch), 1121 
(C-O stretch); 1H NMR (400 MHz, JH-H Hz) d 2.45-2.35 (m, 
5H, H-8b,H-9), 2.51-2.54 (m, 2H, H-5b, H-6b), 2.72-2.64 
(m, 2H, H-7b, H-8a), 2.79-2.74 (m, 2H, H-5a, H-6a), 3.63 
(t, 4H, J 4.6, H-10), 4.16 (dt, 1H, J 13.0, 4.2, H-7a), 6.85 
(s, 1H, H-2), 7.19 (d, 1H, J 8.6, Ph-H), 7.44 (td, 1H, J 7.7, 
1.2, Ph-H), 7.56 (td, 1H, J 7.6, 1.1, Ph-H), 8.01 (dd, 1H, 
J 8.0, 1.2, Ph-H); 13C NMR (125 MHz) d 21.5 (C-6), 34.1 
(C-5), 44.8 (C-7), 53.9 (2C, C-9), 56.9 (C-8), 58.3 (C-2), 
Figure 1. Atom-numbering for thiazinanones 5a-n.
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66.9 (2C, C-10), 126.9, 128.9, 132.7, 135.4, 169.9 (C-4); 
anal. calcd. for C16H21N3O4S: C, 54.69; H, 6.02; N, 11.96; 
found: C, 54.98; H, 6.40; N, 12.01; GC-MS m/z (%): 351 
(M+, 1.5), 113 (42.86), 100 (100), 56 (8).
3-(2-Morpholinoethyl)-2-(3-nitrophenyl)-1,3-thiazinan-4-
one (5b)
White oil; IR (ATR) νmax / cm−1: 3062 (C-Hsp2 stretch), 
2947 and 2816 (C-Hsp3 stretch), 1660 and 1454 (aromatic 
C=C stretch), 1525 and 1348 (NO2 stretch), 1663 (C=O 
stretch), 1117 (C-O stretch); 1H NMR (400 MHz, JH-H Hz) 
d 2.47-2.30 (m, 8H), 2.79-2.69 (m, 1H), 3.66-3.65 (m, 4H, 
H-9), 4,06-3,81 (m, 2H), 5.83 (s, 1H, H-2), 7.57 (m, 2H, Ph-
H), 8.13 (q, 2H, J 7.6, Ph-H); 13C NMR (100 MHz) d 20.1 
(C-6), 39.6 (C-5), 42.3 (C-7), 53.6 (2C, C-9), 55.7 (C-8), 
61.3 (C-2), 66.8 (2C, C-10), 121.9, 123.9, 130.3, 132.7, 
141.9, 148.6, 174.2 (C-4); anal. calcd. for C16H21N3O4S: 
C, 54.69; H, 6.02; N, 11.96; found: C, 54.40; H, 5.97; N, 
11.82; GC-MS m/z (%): 351 (M+, 0.98), 113 (32.21), 100 
(100), 56 (9.14).
3-(2-Morpholinoethyl)-2-(4-nitrophenyl)-1,3-thiazinan-4-
one (5c)
Brown oil; IR (ATR) νmax / cm−1: 3065 (C-Hsp2 stretch), 
2952-2812 (C-Hsp3 stretch), 1596 and 1456 (aromatic 
C=C stretch), 1519 and 1348 (NO2 stretch), 1631 (C=O 
stretch), 1119 (C-O stretch); 1H NMR (400 MHz, JH-H Hz) 
d 2.48-2.33 (m, 5H, H-9, H-8b), 2.66-2.60 (m, 3H, H-5b, 
H-6b, H-8a), 2.81-2.79 (m, 3H, H-5a, H-6a, H-7a), 
3.61-3.58 (m, 4H, H-10), 4.20 (dt, 1H, J 14.0, 5.6, H-7b), 
5.90 (s. 1H, H-2), 7.45 (d, 1H, J 8.6, Ph-H), 8.24 (d, 2H, 
J 8.8, Ph-H); 13C NMR (100 MHz) d 21.8 (C-6), 34.3 
(C-2), 44.9 (C-7), 53.6 (2C, C-9), 56.6 (C-8), 62.0 (C-2), 
67.0 (2C, C-10), 124.3, 127.3, 130.4, 147.6, 171.8 (C-4); 
anal. calcd. for C16H21N3O4S: C, 54.69; H, 6,02; N, 11.96; 
found: C, 54.42; H, 6.10; N, 11.84; GC-MS m/z (%): 351 
(M+, 1.12), 113 (13.12), 100 (100), 44 (2.02).
2-(2-Fluorophenyl)-3-(2-morpholinoethyl)-1,3-thiazinan-4-
one (5d)
Yellow oil; IR (ATR) νmax / cm−1: 2959 (C-Hsp2 stretch), 
2925 and 2863 (C-Hsp3 stretch), 1650 (C=O stretch), 1584-
1422 (aromatic C=C stretch), 1116 (C-O stretch); 1H NMR 
(400 MHz, JH-H Hz) d 2.44-2.34 (m, 5H, H-9, H-8b), 
2.60-2.54 (m, 2H, H-5b, H-6b), 2.67 (dt, 1H, J 13.9, 6.1, 
H-8a), 2.84-2.74 (m, 3H, H-5a, H-6a, H-7b), 3.62-3.60 
(m, 4H, H-10), 4.06 (dt, 1H, J 13.8, 5.4, H-7a), 6.10 (s, 
1H, H-2), 7.00 ( m, 2H, Ph-H), 7.27 (2d, 2H, J 7.2, 6.2, 
Ph-H); 13C NMR (100 MHz, JC-F Hz) d 21.5 (C-6), 34.5 
(C-2), 44.0 (C-7), 53.7 (C-8), 56.0 (2C, C-9), 57.0 (C-2), 
67.0 (2C, C-10), 116.2 (J 20.9), 126.8 (d, J 2.4), 127.0 (d, 
J 11.9), 129.68 (d, J
 
8.3), 159.5 (d, J
 
248.5), 169.3 (C-4); 
GC-MS m/z (%): 324 (M+, 1.65), 113 (43.12), 100 (100), 
86 (5.77), 44 (1.96). 
2-(3-Fluorophenyl)-3-(2-morpholinoethyl)1,3-thiazinan-4-
one (5e)
Yellow oil; IR (ATR) νmax / cm−1: 2961 (C-Hsp2 stretch), 
2947 and 2929 and 2818 (C-Hsp3 stretch), 1618 (C=O stretch), 
1590 and 1402 (aromatic C=C stretch), 1117 (C-O stretch); 
1H NMR (600 MHz, JH-H Hz) d 2.45-2.34 (m, 5H, H-8b, 
H-9), 2.60-2.53 (m, 2H, H-6b, H-8a), 2.81-2.71 (m, 4H, 
H-5a, H-6a, H-5b, H-7b), 3.62-3.57 (m, 4H, H-10), 4.07 (dt, 
1H, J 13.9, 5.1, H-7a), 5.75 (s, 1H, H-2), 6.98-6.91 (m, 3H, 
Ph-H), 7.28 (2d, 1H, J 7.9, 5.8, Ph-H); 13C NMR (150 MHz, 
JC-F Hz ) d 21.8 (C-6), 34.4 (C-2), 44.6 (C-7), 53.8 (C-8), 55.5 
(2C, C-9), 62.2 (C-2), 67.1 (2C, C-10), 113.7 (d, J
 
22.7), 
115.1 ( J 21.2), 122.1 (J 2.8), 130.2 (J 8.4), 142.6 (J 6.5), 
162.9 (d, J 247.3), 169.2 (C-4); GC-MS m/z (%): 324 (1.56), 
113 (30.74), 100 (100), 86 (5.58), 56 (9.32). 
2-(2-Chlorophenyl)-3-(2-morpholinoethyl)1,3-thiazinan-4-
one (5f)
White oil; IR (ATR) νmax / cm−1: 2951 (C-Hsp2 stretch), 
2868 and 2818 (C-Hsp3 stretch), 1668 (C=O stretch), 1594 
and 1409 (aromatic C=C stretch), 1113 (C-O stretch); 
1H NMR (200 MHz, JH-H Hz) d 2.41-2.30 (m, 5H, H-8b, 
H-9), 2.68-2.51(m, 3H, H-5b, H-6b, H-8a), 2.78-2.70 (m, 
1H, H-7b), 2.82-278 (m, 2H, H-5a, H-6a), 3.61 (t, 4H, J 4.7, 
H-10), 4.03-4.01 (m, 1H, H-7a), 6.16 (s, 1H, H-2), 7.01 
(dt, 1H, J 4.7, 3.1, Ph-H), 7.22 (dt, 2H, J 4.6, 4.4, Ph-H), 
7.39 (dt, 1H, J 4.6, 3.8, Ph-H); 13C NMR (50 MHz) d 21.1 
(C-6), 34.4 (C-5), 44.1(C-7), 53.8 (2C, C-9), 56.9 (C-8), 
59.6 (C-2), 67.0 (2C, C-10), 126.5, 126.6, 129.3, 130.27, 
132.6, 136.3, 169.3 (C4); GC-MS m/z (%): 340 (M+, 1.81), 
113 (47.70), 100 (100), 56 (9.89). 
2-(3-Chlorophenyl)-3-(2-morpholinoethyl)-1,3-thiazinan-
4-one (5g)
Yellow oil; IR (ATR) νmax / cm−1: 3050 (C-Hsp2 stretch), 
2935-2809 (C-Hsp3 stretch), 1619 (C=O stretch), 1597 and 
1465 (aromatic C=C stretch), 1109 (C-O stretch); 1H NMR 
(400 MHz, JH-H Hz) d 2.46-2.33 (m, 4H, H-8b, H-9), 2.61-
2.52 ( m, 2H, H-6b, H-8a), 2.81-2.69 (m, 4H, H-5a, H-6a, 
H-7b, H-5b), 3.60 (q, 4H, 3J 4.7, H-10), 4.06 (dt, 1H, J 13.9, 
5.2, H-7a), 5.73 (s, 1H, H-2), 7.07 (dt, 1H, J 6.6, 1.7, Ph-H), 
7.23 (dt, 2H, J 7.9, 6.4, Ph-H); 13C NMR (100 MHz) d 169.3 
(C-4), 141.9, 134.7, 129.8, 126.6, 124.6, 67.0 (2C, C-10), 
62.2 (C-2), 56.6 (C-8), 53.8 (2C, C-9), 44.6 (C-7), 34.4 
(C-5), 21.8 (C-6); anal. calcd. for C16H21N2ClO2S: C, 56.38; 
H, 6.21; N, 8.22; found: C, 56.57; H, 6.23; N, 8.35; GC-MS 
m/z (%): 340 (M+, 1.20), 113 (32.21), 100 (100), 56 (9.14). 
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2-(4-Chlorophenyl)-3-(2-morpholinoethyl)1,3-thiazinan-4-
one (5h) 
White oil; IR (ATR) νmax / cm−1: 2940 (C-Hsp2 stretch), 
2858-2825 (C-Hsp3 stretch), 1508 (C=O stretch), 1576 and 
1463 (aromatic C=C stretch), 1102 (C-O stretch); 1H NMR 
(250 MHz, JH-H Hz) d 2.46-2.36 (m, 5H, H-9, H-8b), 
2.59-2.52 (m, 2H, H-6b, H-8a), 2.79-2.68 (m. 4H, H-5a, 
H-5b, H-6a, H-7b), 3.61-3.59 (m, 4H, H-10), 4.08 (dt, 1H, 
J 13.7, 5.6, H-7a), 5.75 (s, 1H, H-2), 7.13 (d, 2H, J 8.0, 
Ph-H), 7.29 (d, 2H, J 8.3, Ph-H); 13C NMR (100 MHz) 
d 169.3 (C-4), 138.3, 133.9, 128.8, 127.9, 67.0 (2C, C-10), 
62.2 (C-2), 56.5 (C-8), 53.8 (2C, C-9), 44.5 (C-7), 34.5 
(C-5), 21.3 (C-6); GC-MS m/z (%): 340 (M+, 1.14), 113 
(28.16), 100 (100), 86 (5.83), 56 (8.93). 
2-(2-Methoxyphenyl)-3-(2-morpholinoethyl)-1,3-thiazinan-
4-one (5i)
Yellow oil; IR (ATR) νmax / cm−1: 2947 (C-Hsp2 stretch), 
2846-2811 (C-Hsp3 stretch), 1634 (C=O stretch), 1599 and 
1458 (aromatic C=C stretch), 1110 (C-O stretch); 1H NMR 
(600 MHz, JH-H Hz) d 2.42-2.34 (m, 5H, H-8b, H-9), 
2.58-2.51 (m, 2H, H-6b, H-8a), 2.62 (m, 1H, J 13.9, 5.0, 
H-7b), 2.81-2.76 (m, 3H, H-5, H-6a), 3.62 (q, 4H, J 4.4, 
H-10), 3.93 (s, 3H, OCH3), 4.03 (dt, 1H, J 13.6, 4.7, H-7a), 
6.05 (s, 1H, H-2), 6.87 (q, 2H, J 7.1, Ph-H), 6.92 (dd, 1H, 
J 7.5, 1.7, Ph-H), 7.21 (dt, 1H, J 7.7, 1.8, Ph-H); 13C NMR 
(150 MHz) d 21.5 (C-6), 34.6 (C-5), 44.2 (C-7), 53.7 (2C, 
C-9), 56.5 (C-8), 58.6 (C-2), 67.0 (2C, C-10), 111.0, 119.9, 
126.0, 129.2, 155.9, 169.6 (C4); GC-MS m/z (%): 336 (M+, 
3.71), 222 (6.20), 113 (66.26), 100 (100), 56 (11.51). 
2-(3-Methoxyphenyl)-3-(2-morpholinoethyl)1,3-thiazinan-
4-one (5j)
Brown oil; IR (ATR) νmax / cm−1: 2958 (C-Hsp2 stretch), 
2852-2807 (C-Hsp3 stretch), 1611 (C=O stretch), 1507 and 
1458 (aromatic C=C stretch), 1111 (C-O stretch); 1H NMR 
(400 MHz, JH-H Hz) d 2.45-2.34 (m, 5H, H-8b, H-9), 
2.60-2.50 (m, 2H, H-7a, H-8a), 2.79-2.68 (m, 4H, H5, H-6a, 
H-7b), 3.61-3.58 (m, 4H, H-10), 3.74 (s, 3H, OCH3), 4.05 
(dt, 1H, J 13.8, 5.2, H-6b), 5.71 (s, 1H, H-2), 6.91 (dd, 2H, 
J 8.7, 2.0, Ph-H), 7.10 (dd, 1H, J 8.6, 1.7, Ph-H); 13C NMR 
(100 MHz) d 21.5 (C-6), 34.6 (C-5), 44.2 (C-7), 53.7 (2C, 
C-9), 55.3 (OCH3), 56.3 (C-8), 62.3 (C-2), 66.9 (2C, C-10), 
114.0, 127.8, 131.3, 159.4, 169.4 (C-4); GC-MS m/z (%): 
336 (M+, 2.55), 222 (1.68), 113 (42.86), 100 (100), 56 (9.69). 
2-(4-Methoxyphenyl)-3-(2-morpholinoethyl)1,3-thiazinan-
4-one (5k)
Yellow oil; IR (ATR) νmax / cm−1: 2941 (C-Hsp2 stretch), 
2851 (C-Hsp3 stretch), 1601 and 1460 (aromatic C=C stretch), 
1627 (C=O stretch), 1115 (C-O stretch); 1H NMR (400 MHz, 
JH-H Hz) d 2.45-2.33 (m, 5H, H-9, H-8b), 2.62-2.50 ( m, 2H, 
H-6b, H-8a), 2.78-2.71 (m, 4H, H-7b, H-5, H-6a), 3.6-3.56 
(m, 4H, H-10), 3.74 (s, 3H, OCH3), 4.05 (dt, 1H, J 13.8, 5.3, 
H-7a), 5.71 (s, 1H, H-2), 6.81 (d, 2H, J 8.7, Ph-H), 7.09 (d, 
2H, J 8.7, Ph-H); 13C NMR (125 MHz) d 21.8 (C-6), 34.5 
(C-5), 53.8 (2C, C-9), 55.4 (OCH3), 56.4 (C-8), 62.45 (C-2), 
67.0 (2C, C-10), 114.0, 127.8, 132.3, 159.4, 169.5 (C4); 
GC-MS m/z (%): 336 (M+, 2.14), 222 (6.70), 113 (36.21), 
100 (100), 86 (5.48), 44 (2.70). 
2-(2-Hydroxyphenyl)-3-(2-morpholinoethyl)1,3-thiazinan-
4-one (5l)
Brown oil; IR (ATR) νmax / cm−1: 3344 (OH stretch), 
3070 (C-Hsp2 stretch), 2950 and 2899 (C-Hsp3 stretch), 1615 
(C=O stretch), 1591 and 1441 (aromatic C=C stretch), 1115 
(C-O stretch); 1H NMR (600 MHz, JH-H Hz) d 2.51-2.42 (m, 
5H, H-8b, H-9), 2.60-2.54 (m, 2H, H-6b, H-8a), 2.83-2.70 
(m, 4H, H5, H-6a, H-7b), 3.62 (q, 4H, J 4.2, H-10), 4.08 
(dt, 1H, J 13.8, 5.3, H-7a), 5.65 (s, 1H, H-2), 6.73 (dd, 
2H, J 7.9, 1.8, Ph-H), 7.00 (d, 2H, J 7.9, Ph-H); 13C NMR 
(150 MHz) d 21.7 (C-6), 34.4 (C-5), 44.4 (C-7), 62.5 (C-2), 
53.6 (2C, C-9), 56.1 (C-8), 66.7 (2C, C-10), 115.5, 127.8, 
129.8, 156.7, 170.0 (C4); GC-MS m/z (%): 322 (M+, 0.50), 
113 (43.55), 100 (100), 86 (2.17), 44 (20.68).
2-(3-Hydroxyphenyl)-3-(2-morpholinoethyl)1,3-thiazinan-
4-one (5m)
Brown oil; IR (ATR) νmax / cm−1: 3244 (OH stretch), 
2949 (C-Hsp2 stretch), 2944 (OH stretch), 2861 and 2820 
(C-Hsp3 stretch), 1605 (C=O stretch), 1526-1456 (aromatic 
C=C stretch), 1108 (C-O stretch); 1H NMR (400 MHz, 
JH-H Hz) d 2.50-2.38 (m, 5H, H-8b, H-9), 2.60-2.54 (m, 
2H, H-6b, H-8a), 2.84-2.72 (m, 4H, H-5, H-6a, H-7a), 3.61 
(q, 4H, J 4.2, H10), 4.09 (dt, 1H, J 13.8, 5.3, H7b), 5.69 
(s, 1H, H2), 6.62 (d, 1H, J 1.8, Ph-H), 6.71 (dd, 2H, J 7.9, 
1.8, Ph-H), 7.24 (d, 2H, J 7.9, Ph-H); 13C NMR (100 MHz) 
d 21.6 (C-6), 34.5 (C-5), 44.8 (C-7), 54.7 (2C, C-9), 57.3 
(C-8), 63.6 (C-2), 67.9 (2C, C-10), 114.1, 116.3, 119.5, 
131.2, 141.9, 157.7, 170.9 (C4); GC-MS m/z (%): 322 (M+, 
1.23), 113 (35.67), 100 (100), 86 (6.93), 44 (2.00).
2-(4-Hydroxyphenyl)-3-(2-morpholinoethyl)1,3-thiazinan-
4-one (5n) 
Yellow oil; IR (ATR) νmax / cm−1: 3305 (OH stretch), 
3056 (C-Hsp2 stretch), 2970 and 2869 (C-Hsp3 stretch), 1636 
(C=O stretch), 1610 and 1461 (aromatic C=C stretch), 1112 
(C-O stretch); 1H NMR (600 MHz, JH-H Hz) d 2.50-2.42 (m, 
5H, H-8b, H-9), 2.60-2.54 (m, 2H, H-6b, H-8a), 2.84-2.70 
(m, 4H, H-5, H-6a, H-7b), 3.44 (dt, 1H, J 13.3, 5.7, H-7a), 
3.71 (q, H4, J 4.6, H-10), 4.16 (dt, 1H, J 13.7, 5.6, H-6b), 
5.74 (s, 1H, H-2), 6.82 (d, 2H, J 8.6, Ph-H), 7.08 (d, 2H, 
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J 8.5, Ph-H); 13C NMR (150 MHz) d 21.7 (C-6), 34.5 (C-5), 
44.4 (C-7), 53.7 (2C, C-9), 56.2 (C-8), 62.5 (C-2), 66.7 (2C, 
C-10), 115.6, 127.9, 156.8, 170.1 (C-4); GC-MS m/z (%): 
322 (M+, 1.36), 113 (32.58), 100 (100), 86 (7.14), 44 (3.09).
Results and Discussion
One-pot synthesis of thiazinanones by the conventional 
thermal heating method 
To the synthesis of thiazinanones 5a-n, three components 
were used as the starting materials: the mercaptoacetic acid, 
arenealdehydes bearing electron-withdrawn or electron-
releasing groups, and the 2-morpholinoethylamine. The 
choice for 2-morpholinoethylamine as amine core was 
due the biological importance of heterocyclic morpholine. 
Compounds with this scaffold feature a wide range of 
biological activities, recently reviewed by Pal´chkov.20
Our first purpose was the synthesis of heterocycles by 
the conventional thermal heating methodology (Scheme 1). 
The expected compounds were synthesized through the 
one-pot reaction procedure in toluene refluxing. In this 
procedure, the intermediate imine was completely formed 
(3 h) before the cyclocondensation step to the thiazinanones 
(16 h). The water was removed by azeotropic distillation 
using a Dean-Stark apparatus and the progresses of all 
reactions were monitored by thin layer chromatography 
(TLC) and/or by GC. The heterocycles were obtained 
in moderate to excellent yields after the purification by 
washing with hot hexane/ethyl acetate (9:1). 
Sonification effect on the multicomponent synthesis of 
thiazinanones
The six-membered thiazinanone has structural 
similarity to the five-membered thiazolidinone, so the 
reaction condition using ultrasound was based in such 
heterocycle, according to a recent work published by us.12 
2-Morpholinoethylamine is an aliphatic amine and the first 
experiment was carried out in a multicomponent reaction 
of amine 2, 2-nitrobenzaldehyde 1a and mercaptopropionic 
acid 4 (3 equivalents) in toluene for 5 min. However, it was 
observed the starting material aldehyde in TLC and GC. 
The next experiment was monitored by TLC in ten, fifteen, 
twenty and twenty-five minutes. The complete formation 
of thiazinanone 5a (up to 99% in GC) was observed in 
25 min. The product was isolated and all spectrometric and 
spectroscopic data are identical to those for thiazinanone 
5a prepared by the conventional method. Further, the 
proportion of the mercaptopropionic acid 4 was also studied 
and no significant difference on yields was found when 1, 
2 or 3 equivalents of acid were used.
Found the best condition, the synthesis of all 
thiazinanones 5a-n were carried out in a mixture of 1 mmol 
of arenaldehydes 1a-n, 1 mmol of amine 2 and 1 mmol of 
the mercaptopropionic acid 4 that was sonicated for 25 min 
in toluene (Scheme 2). The heterocycles 5a-n were obtained 
in a range of 41-88%, without further purification. 
The comparative yields of thiazinanones 5a-n 
are summarized in Table 1. The electronic nature of 
arenealdehyde substituent did not affect the yields 
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Scheme 1. (i) Toluene, 110 °C, 3h; (ii) HSCH2CH2COOH, 110 °C, 16h (49-97%).
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Scheme 2. (i) Toluene, HSCH2CH2COOH, ultrasound, r.t., 25 min (41-88%).
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of products as well the position, with exception for 
thiazinanones 5l-n bearing a phenolic group that showed 
lower yields. A possible explanation is the polar hydroxyl 
group that increase water solubility and an amount of 
product might be lost in the extraction procedure. 
As we expected, the sonochemisty methodology 
afford the pure thiazinanones in lower reaction times than 
conventional heating (25 minutes to 19 hours) in quite 
similar yields. Other important advantage of ultrasound 
methodology is the absence of water remove procedure, 
e.g., azeotropic distillation, desiccant agents. 
The fourteen unpublished thiazinanones were 
identified and characterized by mass spectrometry and 
1H and 13C NMR spectroscopy. The 2D NMR techniques 
heteronuclear multiple quantum correlation (HMQC) 
and heteronuclear multiple bond correlation (HMBC) 
were necessary to the correct assignments of hydrogens 
and carbons. The 1H NMR spectrum shows that the 
aromatic signals appear in the range of 8.24-7.00 ppm, 
the H2 hydrogen as a singlet at 6.85-5.68 ppm. The H10 
and H9 of the morpholine ring are assigned as a triplet 
or multiplet at 3.63-3.57 ppm and as a multiplet in the 
range of 2.48-2.33 ppm, respectively. The H7a of ethylene 
bridge is shown as a double triplet at 4.20-4.06 ppm 
(2J = 14.0-13.0 Hz, 3J = 5.6-4.2 Hz) and H7b and H8 
appear as multiplets with superposition of signals. The 
four diastereotopic H5 and H6 of thiazinanone ring are 
shown as multiplets due the superposition of signals in 
the range of 2.82-2.51 ppm. In 13C NMR, the C10 and 
C9 of morpholine ring appear at 66.7-67.9 ppm and 
53.6-56.0 ppm, respectively. The chemical shift of ethylene 
carbons shows that C8 is deshilded at 67.9-66.7 ppm and 
C7 are shielded at 56.0-53.6 ppm, according to HMQC 
spectra. The carbons of thiazinanones are assigned as 
174.2-169.2 ppm for the carbonyl (C4), 62.2-57.0 ppm 
for the C2, 34.6-34.1 ppm for C5 and 21.8-21.5 ppm for 
C6. The HMBC confirm the assignment of C5 and C6. 
Conclusions 
Therefore, the sonochemistry was efficient as an 
attractive strategy to promote the synthesis of thiazinanones 
through a multicomponent reaction. The products were 
obtained in good yields in shorter reaction times (25 min) 
when compared to thermal heating methodology (19 h). 
In addition, no water removal was necessary when the 
ultrasound was used.
Suplemantary Information
Supplementary information with analytical data (mass, 
1H and 13C NMR and infrared spectra) is available free of 
charge at http://jbcs.sbq.org.br as PDF file.
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